Terazosin Capsule
Product Images NDC 63629-2439

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 63629-2439). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292439)

Label for Terazosin Capsules, USP 10 mg from Bryant Ranch Prepack. The label includes the NDC number 63629-2439-1, dosage strength, and package count of 100 capsules. It shows storage instructions, manufacturer Jubilant Cadista Pharmaceuticals, and a barcode. The label states Rx only and includes handling warnings to protect from light and moisture.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin Hydrochloride, showing its molecular formula with ring structures, amine group, ether, and hydrochloride component.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

This image presents two line graphs comparing the effects of Terazosin and placebo over a three-month period. The left graph illustrates the mean change in total symptom score from baseline, showing a decrease over time for Terazosin and minimal change for placebo. The right graph depicts the mean increase in peak flow rate (mL/sec) from baseline, with Terazosin showing a notable increase compared to placebo. Sample sizes for each group are indicated, with error bars representing variability.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line chart showing mean change from baseline over time in months. The x-axis represents months from 0 to 30, and the y-axis shows the mean change from baseline, ranging from 0 to -7. Data points are marked with circles and some points are indicated with asterisks, suggesting statistical significance or notable results at those times.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

A line graph plotting mean change from baseline (measured in mL/sec) over a 30-month period. The x-axis represents months from 0 to 30, and the y-axis shows the mean change values ranging approximately from 0 to 4.5. Data points are marked with error bars, and several have asterisks indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.